{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-053009","form_type":"8-K","ticker":"AXSM","cik":"0001579428","company_name":"Axsome Therapeutics, Inc.","filed_at":"2026-02-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.517683+00:00","generated_at":"2026-05-16T02:26:04.131855+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Axsome settles SUNOSI patent litigation; generic entry delayed to 2040","bullets":["Alkem can sell generic SUNOSI on/after March 1, 2040 (no pediatric exclusivity) or September 1, 2040 (if granted), subject to FDA approval.","Settlement resolves Alkem's ANDA patent litigation in District of New Jersey; similar litigation with another party remains pending.","Agreement submitted to FTC and DOJ for review as required by law.","No financial terms disclosed in the settlement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-053009","json":"https://secwatch.observer/filing/0001193125-26-053009.json","markdown":"https://secwatch.observer/filing/0001193125-26-053009.md","text":"https://secwatch.observer/filing/0001193125-26-053009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1579428/000119312526053009/0001193125-26-053009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1579428/000119312526053009/axsm-20260217.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T02:26:04.131855+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}